tbuckley/cabot-search huggingface dataset:
Near‐infrared light-triggered nitric oxide nanocomposites for photodynamic/photothermal complementary therapy against periodontal biofilm in an animal model
Authors: Xiangrong Wu, Manlin Qi, Chengyu Liu, Qijing Yang, Sijia Li, Fangyu Shi, Xiaolin Sun, Lin Wang, Chunyan Li, Biao Dong
Journal: Theranostics (2023)

Background: Periodontal disease, an oral disease that initiates with plaque biofilm infection, affects 10% of the global population.Due to the complexity of tooth root anatomy, biofilm resistance and antibiotic resistance, traditional mechanical debridement and antibiotic removal of biofilms are not ideal.Nitric oxide (NO) gas therapy and its multifunctional therapy are effective methods to clear biofilms.However, large and controlled delivery of NO gas molecules is currently a great challenge.Methods: The core-shell structure of Ag2S@ZIF-90/Arg/ICG was developed and characterized in detail.The ability of Ag2S@ZIF-90/Arg/ICG to produce heat, ROS and NO under 808 nm NIR excitation was detected by an infrared thermal camera, probes and Griess assay.In vitro anti-biofilm effects were evaluated by CFU, Dead/Live staining and MTT assays.Hematoxylin-eosin staining, Masson staining and immunofluorescence staining were used to analyze the therapeutic effects in vivo.Results: Antibacterial photothermal therapy (aPTT) and antibacterial photodynamic therapy (aPDT) could be excited by 808 nm NIR light, and the produced heat and ROS further triggered the release of NO gas molecules simultaneously.The antibiofilm effect had a 4-log reduction in vitro.The produced NO caused biofilm dispersion through the degradation of the c-di-AMP pathway and improved biofilm eradication performance.In addition, Ag2S@ZIF-90/Arg/ICG had the best therapeutic effect on periodontitis and NIR II imaging ability in vivo.Conclusions: We successfully prepared a novel nanocomposite with NO synergistic aPTT and aPDT.It had an outstanding therapeutic effect in treating deep tissue biofilm infection.This study not only enriches the research on compound therapy with NO gas therapy but also provides a new solution for other biofilm infection diseases.
US Health Care System Earns Poor Marks
Authors: Rebecca Voelker
Journal: JAMA (2008)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Implantable Cardioverter–Defibrillators after Myocardial Infarction
Authors: Robert J. Myerburg
Journal: New England Journal of Medicine (2008)

Patients with a history of myocardial infarction and a reduced ejection fraction are at increased risk for life-threatening ventricular arrhythmias. Which of these patients are the most appropriate candidates for implantable cardioverter–defibrillator (ICD) therapy is unclear. Factors influencing the decision are discussed.
Risk Factors for Infection at the Operative Site after Abdominal or Vaginal Hysterectomy
Authors: Mervyn Shapiro, Alvaro Muñoz, Ira B. Tager, Stephen C. Schoenbaum, B. Frank Polk
Journal: New England Journal of Medicine (1982)

We studied risk factors for postoperative infections at the operative site after hysterectomies. Data were collected prospectively on all women undergoing vaginal hysterectomies (323 patients) or abdominal hysterectomies (1125 patients) at the Boston Hospital for Women between February 1976 and April 1978. Logistic-regression analysis indicated that factors significantly associated (P<0.05) with a higher risk of infection at the operative site were increased duration of operation, lack of antibiotic prophylaxis, younger age, being a clinic patient, and an abdominai approach. After these variables were accounted for, the variables of obesity, preoperative functional and anatomical diagnoses, postoperative anatomical and pathological diagnoses, estimated blood loss, menopausal status, and operation by a specific surgeon did not add predictive power. An increasing duration of operation was associated with a decreasing effect of antibiotic prophylaxis, the preventive fraction of which diminished from 80 per cent at one hour to an unmeasurable effect at 3.3 hours. (N Engl J Med. 1982; 307:1661–6.)
Using machine learning to predict antibody response to SARS-CoV-2 vaccination in solid organ transplant recipients: the multicentre ORCHESTRA cohort
Authors: Maddalena Giannella, Manuel Huth, Elda Righi, Jan Hasenauer, Lorenzo Marconi, Angelina Konnova, Akshita Gupta, An Hotterbeekx, Matilda Berkell, Zaira R. Palacios-Baena, Maria Cristina Morelli, Mariarosa Tamè, Marco Busutti, Luciano Potena, Elena Salvaterra, Giuseppe Feltrin, Gino Gerosa, Lucrezia Furian, Patrizia Burra, Salvatore Piano, Umberto Cillo, Mara Cananzi, Monica Loy, Gianluigi Zaza, Francesco Onorati, Amedeo Carraro, Fiorella Gastaldon, Maurizio Nordio, Samir Kumar-Singh, Jesús Rodríguez Baño, Tiziana Lazzarotto, Pierluigi Viale, Evelina Tacconelli
Journal: Clinical Microbiology and Infection (2023)
Dysregulation of metabolic pathways in pulmonary fibrosis
Authors: Rishi Rajesh, Reham Atallah, Thomas Bärnthaler
Journal: Pharmacology & Therapeutics (2023)

Idiopathic pulmonary fibrosis (IPF) is a chronic progressive disorder of unknown origin and the most common interstitial lung disease. It progresses with the recruitment of fibroblasts and myofibroblasts that contribute to the accumulation of extracellular matrix (ECM) proteins, leading to the loss of compliance and alveolar integrity, compromising the gas exchange capacity of the lung. Moreover, while there are therapeutics available, they do not offer a cure. Thus, there is a pressing need to identify better therapeutic targets. With the advent of transcriptomics, proteomics, and metabolomics, the cellular mechanisms underlying disease progression are better understood. Metabolic homeostasis is one such factor and its dysregulation has been shown to impact the outcome of IPF. Several metabolic pathways involved in the metabolism of lipids, protein and carbohydrates have been implicated in IPF. While metabolites are crucial for the generation of energy, it is now appreciated that metabolites have several non-metabolic roles in regulating cellular processes such as proliferation, signaling, and death among several other functions. Through this review, we succinctly elucidate the role of several metabolic pathways in IPF. Moreover, we also discuss potential therapeutics which target metabolism or metabolic pathways.
Gut microbiota maturity mediates the protective effect of siblings on food allergy
Authors: Yuan Gao, Jakob Stokholm, Martin O’Hely, Anne-Louise Ponsonby, Mimi L.K. Tang, Sarath Ranganathan, Richard Saffery, Leonard C. Harrison, Fiona Collier, Lawrence Gray, David Burgner, John Molloy, Peter D. Sly, Susanne Brix, Hanne Frøkiær, Peter Vuillermin
Journal: Journal of Allergy and Clinical Immunology (2023)
Retinol-binding protein-hijacking nanopolyplex delivering siRNA to cytoplasm of hepatic stellate cell for liver fibrosis alleviation
Authors: Jinsheng Huang, Huiling Huang, Yiyao Wang, Bin Xu, Minzhao Lin, Shisong Han, Yuanyuan Yuan, Yong Wang, Xintao Shuai
Journal: Biomaterials (2023)
A paradigm for high-throughput screening of cell-selective surfaces coupling orthogonal gradients and machine learning-based cell recognition
Authors: Hongye Hao, Yunfan Xue, Yuhui Wu, Cong Wang, Yifeng Chen, Xingwang Wang, Peng Zhang, Jian Ji
Journal: Bioactive Materials (2023)

The combinational density of immobilized functional molecules on biomaterial surfaces directs cell behaviors. However, limited by the low efficiency of traditional low-throughput experimental methods, investigation and optimization of the combinational density remain daunting challenges. Herein, we report a high-throughput screening set-up to study biomaterial surface functionalization by integrating photo-controlled thiol-ene surface chemistry and machine learning-based label-free cell identification and statistics. Through such a strategy, a specific surface combinational density of polyethylene glycol (PEG) and arginine-glutamic acid-aspartic acid-valine peptide (REDV) leads to high endothelial cell (EC) selectivity against smooth muscle cell (SMC) was identified. The composition was translated as a coating formula to modify medical nickel-titanium alloy surfaces, which was then proved to improve EC competitiveness and induce endothelialization. This work provided a high-throughput method to investigate behaviors of co-cultured cells on biomaterial surfaces modified with combinatorial functional molecules.
Design of external quality assessment schemes and definition of the roles of their providers in future epidemics
Authors: Christoph Buchta, Heinz Zeichhardt, Stephan W Aberle, Jeremy V Camp, Irene Görzer, Lukas Weseslindtner, Elisabeth Puchhammer-Stöckl, Wolfgang Huf, Bernhard Benka, Franz Allerberger, Martin Mielke, Andrea Griesmacher, Mathias M Müller, Ingo Schellenberg, Martin Kammel
Journal: The Lancet Microbe (2023)

During an epidemic, individual test results form the basis of epidemiological indicators such as case numbers or incidence. Therefore, the accuracy of measures derived from these indicators depends on the reliability of individual results. In the COVID-19 pandemic, monitoring and evaluating the performance of the unprecedented number of testing facilities in operation, and novel testing systems in use, was urgently needed. External quality assessment (EQA) schemes are unique sources of data reporting on testing performance, and their providers are recognised contacts and support for test facilities (for technical–analytical topics) and health authorities (for planning the monitoring of infection diagnostics). To identify information provided by SARS-CoV-2 genome detection EQA schemes that is relevant for public health microbiology, we reviewed the current literature published in PubMed between January, 2020, and July, 2022. We derived recommendations for EQA providers and their schemes for best practices to monitor pathogen-detection performance in future epidemics. We also showed laboratories, test facilities, and health authorities the information and benefits they can derive from EQA data, and from the non-EQA services of their providers.
Relationship between clinic and ambulatory blood pressure and mortality: an observational cohort study in 59 124 patients
Authors: Natalie Staplin, Alejandro de la Sierra, Luis M Ruilope, Jonathan R Emberson, Ernest Vinyoles, Manuel Gorostidi, Gema Ruiz-Hurtado, Julián Segura, Colin Baigent, Bryan Williams
Journal: The Lancet (2023)

Ambulatory blood pressure provides a more comprehensive assessment than clinic blood pressure, and has been reported to better predict health outcomes than clinic or home pressure. We aimed to examine associations of clinic and 24-h ambulatory blood pressure with all-cause and cardiovascular mortality in a large cohort of primary care patients referred for assessment of hypertension.
Switching to once-weekly insulin icodec versus once-daily insulin glargine U100 in individuals with basal-bolus insulin-treated type 2 diabetes (ONWARDS 4): a phase 3a, randomised, open-label, multicentre, treat-to-target, non-inferiority trial
Authors: Chantal Mathieu, Björg Ásbjörnsdóttir, Harpreet S Bajaj, Wendy Lane, Ana Laura S A Matos, Sreenivasa Murthy, Karolina Stachlewska, Julio Rosenstock
Journal: The Lancet (2023)
Sintilimab plus chemotherapy for patients with EGFR-mutated non-squamous non-small-cell lung cancer with disease progression after EGFR tyrosine-kinase inhibitor therapy (ORIENT-31): second interim analysis from a double-blind, randomised, placebo-controlled, phase 3 trial
Authors: Shun Lu, Lin Wu, Hong Jian, Ying Cheng, Qiming Wang, Jian Fang, Ziping Wang, Yanping Hu, Liang Han, Meili Sun, Liyun Miao, Cuimin Ding, Jiuwei Cui, Ke Wang, Baolan Li, Xingya Li, Feng Ye, Anwen Liu, Yueyin Pan, Shundong Cang, Hui Zhou, Xing Sun, Yuping Shen, Shuyan Wang, Wen Zhang, Yue He
Journal: The Lancet Respiratory Medicine (2023)
Incidence, prevalence, and co-occurrence of autoimmune disorders over time and by age, sex, and socioeconomic status: a population-based cohort study of 22 million individuals in the UK
Authors: Nathalie Conrad, Shivani Misra, Jan Y Verbakel, Geert Verbeke, Geert Molenberghs, Peter N Taylor, Justin Mason, Naveed Sattar, John J V McMurray, Iain B McInnes, Kamlesh Khunti, Geraldine Cambridge
Journal: The Lancet (2023)
Exercise alleviates neovascular age-related macular degeneration by inhibiting AIM2 inflammasome in myeloid cells
Authors: Bohao Cui, Xu Guo, Wei Zhou, Xiaodan Zhang, Kai He, Tinghui Bai, Dongxue Lin, Selena Wei-Zhang, Yan Zhao, Shengnan Liu, Hui Zhou, Qing Wang, Xueming Yao, Ying Shi, Ruotian Xie, Xue Dong, Yi Lei, Mei Du, Yongsheng Chang, Heping Xu, Dongming Zhou, Ying Yu, Xiaohong Wang, Hua Yan
Journal: Metabolism (2023)

The neovascular form of age-related macular degeneration (nvAMD) is the leading cause of blindness in the elderly population. Vascular endothelial growth factor (VEGF) plays a crucial role in choroidal neovascularization (CNV), and anti-VEGF therapy is recommended as first-line therapy for nvAMD. However, many patients do not radically benefit from this therapy. Epidemiological data suggest that physical exercise is beneficial for many human diseases, including nvAMD. Yet, its protective mechanism and therapeutic potential remain unknown. Here, using clinical samples and mouse models, we found that exercise reduced CNV and enhanced anti-angiogenic therapy efficacy by inhibiting AIM2 inflammasome activation. Furthermore, transfusion of serum from exercised mice transferred the protective effects to sedentary mice. Proteomic data revealed that exercise promoted the release of adiponectin, an anti-inflammatory adipokine from adipose tissue into the circulation, which reduced ROS-mediated DNA damage and suppressed AIM2 inflammasome activation in myeloid cells of CNV eyes through AMPK-p47phox pathway. Simultaneous targeting AIM2 inflammasome product IL-1β and VEGF produced a synergistic effect for treating choroidal neovascularization. Collectively, this study highlights the therapeutic potential of an exercise-AMD axis and uncovers the AIM2 inflammasome and its product IL-1β as potential targets for treating nvAMD patients and enhancing the efficacy of anti-VEGF monotherapy.
Complement-dependent mpox-virus-neutralizing antibodies in infected and vaccinated individuals
Authors: Mathieu Hubert, Florence Guivel-Benhassine, Timothée Bruel, Françoise Porrot, Delphine Planas, Jessica Vanhomwegen, Aurélie Wiedemann, Sonia Burrel, Stéphane Marot, Romain Palich, Gentiane Monsel, Harouna Diombera, Sébastien Gallien, Jose Luis Lopez-Zaragoza, William Vindrios, Fabien Taieb, Sandrine Fernandes-Pellerin, Maurine Delhaye, Hélène Laude, Laurence Arowas, Marie-Noelle Ungeheuer, Laurent Hocqueloux, Valérie Pourcher, Thierry Prazuck, Anne-Geneviève Marcelin, Jean-Daniel Lelièvre, Christophe Batéjat, Yves Lévy, Jean-Claude Manuguerra, Olivier Schwartz
Journal: Cell Host & Microbe (2023)
Phase III Study Comparing Cisplatin Plus Gemcitabine With Cisplatin Plus Pemetrexed in Chemotherapy-Naive Patients With Advanced-Stage Non–Small-Cell Lung Cancer
Authors: Giorgio Vittorio Scagliotti, Purvish Parikh, Joachim von Pawel, Bonne Biesma, Johan Vansteenkiste, Christian Manegold, Piotr Serwatowski, Ulrich Gatzemeier, Raghunadharao Digumarti, Mauro Zukin, Jin S. Lee, Anders Mellemgaard, Keunchil Park, Shehkar Patil, Janusz Rolski, Tuncay Goksel, Filippo de Marinis, Lorinda Simms, Katherine P. Sugarman, David Gandara
Journal: Journal of Clinical Oncology (2023)

Cisplatin plus gemcitabine is a standard regimen for first-line treatment of advanced non-small-cell lung cancer (NSCLC). Phase II studies of pemetrexed plus platinum compounds have also shown activity in this setting.
A new class of potent liver injury protective compounds: Structural elucidation, total synthesis and bioactivity study
Authors: Kailong Ji, Wei Liu, Weihang Yin, Xiangrong Kong, Honghong Xu, Zeng-Wei Lai, Jing-Ya Li, Jian-Min Yue
Journal: Acta Pharmaceutica Sinica B (2023)

A new class of potent liver injury protective compounds, phychetins A−D (1−4) featuring an unique 6/6/5/6/5 pentacyclic framework, were isolated and structurally characterized from a Chinese medicinal plant Phyllanthus franchetianus. Compounds 2−4 are three pairs of enantiomers that were initially obtained in a racemic manner, and were further separated by chiral HPLC preparation. Compounds 1−4 were proposed to be originated biosynthetically from a coexisting lignan via an intramolecular Friedel–Crafts reaction as the key step. A bioinspired total synthesis strategy was thus designated, and allowed the effective syntheses of compounds 2−4 in high yields. Some of compounds exhibited significant anti-inflammatory activities in vitro via suppressing the production of pro-inflammatory cytokine IL-1β. Notably, compound 4, the most active enantiomeric pair in vitro, displayed prominent potent protecting activity against liver injury at a low dose of 3 mg/kg in mice, which could serve as a promising lead for the development of acute liver injury therapeutic agent.
Semantic similarity metrics for image registration
Authors: Steffen Czolbe, Paraskevas Pegios, Oswin Krause, Aasa Feragen
Journal: Medical Image Analysis (2023)

Image registration aims to find geometric transformations that align images. Most algorithmic and deep learning-based methods solve the registration problem by minimizing a loss function, consisting of a similarity metric comparing the aligned images, and a regularization term ensuring smoothness of the transformation. Existing similarity metrics like Euclidean Distance or Normalized Cross-Correlation focus on aligning pixel intensity values or correlations, giving difficulties with low intensity contrast, noise, and ambiguous matching. We propose a semantic similarity metric for image registration, focusing on aligning image areas based on semantic correspondence instead. Our approach learns dataset-specific features that drive the optimization of a learning-based registration model. We train both an unsupervised approach extracting features with an auto-encoder, and a semi-supervised approach using supplemental segmentation data. We validate the semantic similarity metric using both deep-learning-based and algorithmic image registration methods. Compared to existing methods across four different image modalities and applications, the method achieves consistently high registration accuracy and smooth transformation fields.
Tralokinumab shows clinical improvement in patients with prurigo nodularis-like phenotype atopic dermatitis: A multicenter, prospective, open-label case series study
Authors: Elena Pezzolo, Alessio Gambardella, Mario Guanti, Tommaso Bianchelli, Alberto Bertoldi, Alfredo Giacchetti, Massino Donini, Giuseppe Argenziano, Luigi Naldi
Journal: Journal of the American Academy of Dermatology (2023)
Comparison of disease phenotypes and mechanistic insight on causal variants in patients with DADA2
Authors: Liang Chen, Anna Mamutova, Anna Kozlova, Elena Latysheva, Frolov Evgeny, Tatiana Latysheva, Kirill Savostyanov, Alexander Pushkov, Ilya Zhanin, Elena Raykina, Maria Kurnikova, Irina Mersiyanova, Craig D. Platt, Hyuk Jee, Kailey Brodeur, Yan Du, Meng Liu, Aaron Weiss, Grant S. Schulert, Jackeline Rodriguez-Smith, Michael S. Hershfield, Ivona Aksentijevich, Qing Zhou, Peter A. Nigrovic, Anna Shcherbina, Ekaterina Alexeeva, Pui Y. Lee
Journal: Journal of Allergy and Clinical Immunology (2023)
Prevalence and burden of atopic dermatitis involving the head, neck, face, and hand: A cross sectional study from the TARGET-DERM AD cohort
Authors: Jonathan I. Silverberg, Brenda Simpson, Katrina Abuabara, Emma Guttman-Yassky, Brian Calimlim, Colleen Wegzyn, Whitney Krueger, Amy Gamelli, Breda Munoz, Rachel W. Faller, Julie M. Crawford, Ayman Grada, Lawrence F. Eichenfield
Journal: Journal of the American Academy of Dermatology (2023)
Mosaic Chromosomal Alterations Are Associated With Increased Lung Cancer Risk: Insight From the INTEGRAL-ILCCO Cohort Analysis
Authors: Chao Cheng, Wei Hong, Yafang Li, Xiangjun Xiao, James McKay, Younghun Han, Jinyoung Byun, Bo Peng, Demetrios Albanes, Stephen Lam, Adonina Tardon, Chu Chen, Stig E. Bojesen, Maria T. Landi, Mattias Johansson, Angela Risch, Heike Bickeböller, H-Erich Wichmann, David C. Christiani, Gad Rennert, Susanne Arnold, Gary Goodman, John K. Field, Michael P.A. Davies, Sanjay S. Shete, Loic Le Marchand, Geoffrey Liu, Rayjean J. Hung, Angeline S. Andrew, Lambertus A. Kiemeney, Meng Zhu, Hongbing Shen, Shan Zienolddiny, Kjell Grankvist, Mikael Johansson, Angela Cox, Yun-Chul Hong, Jian-Min Yuan, Philip Lazarus, Matthew B. Schabath, Melinda C. Aldrich, Paul Brennan, Yong Li, Olga Gorlova, Ivan Gorlov, Christopher I. Amos
Journal: Journal of Thoracic Oncology (2023)
A non-canonical enzymatic function of PIWIL4 maintains genomic integrity and leukemic growth in AML
Authors: Shiva Bamezai, Alex Jose Pulikkottil, Tribhuwan Yadav, Vegi Mahalakshmi Naidu, Julia Mueller, Jasmin Mark, Tamoghna Mandal, Kristin Anja Feder, Susann Lehle, Chenlin Song, Reinhild Rosler, Sebastian Wiese, Jessica I Hoell, Andreas Kloetgen, Aly Karsan, Ankita Kumari, Luke Wojenski, Amit U Sinha, Irene Gonzalez-Menendez, Leticia Quintanilla-Martinez, Elisa Donato, Andreas Trumpp, Elisabeth Kruse, Stephan Hamperl, Lee Zou, Vijay P. S. Rawat, Christian Buske
Journal: Blood (2023)
Hepatic niche leads to aggressive natural killer cell leukemia proliferation through transferrin-transferrin receptor 1 axis
Authors: Kazuaki Kameda, Ryo Yanagiya, Yuji Miyatake, Joaquim Carreras, Hiroshi Higuchi, Hiromichi Murayama, Takashi Ishida, Asahi Ito, Shinsuke Iida, Noriko Fukuhara, Hideo Harigae, Yuki Fujioka, Naoto Takahashi, Hidenori Wada, Fumihiro Ishida, Hideyuki Nakazawa, Rei Ishihara, Yuki Murakami, Hiroyuki Tagawa, Tadashi Matsuura, So Nakagawa, Sadahiro Iwabuchi, Shinichi Hashimoto, Ken-Ichi Imadome, Naoya Nakamura, Kenichi Ishizawa, Yoshinobu Kanda, Kiyoshi Ando, Ai Kotani
Journal: Blood (2023)
Genetic events associated with venetoclax resistance in CLL identified by whole-exome sequencing of patient samples
Authors: Jasneet Kaur Khalsa, Justin Cha, Filippo Utro, Aishath Naeem, Ishwarya Murali, Yanan Kuang, Kevin Vasquez, Liang Li, Svitlana Tyekucheva, Stacey M. Fernandes, Lauren Veronese, Romain Guieze, Binu Kandathilparambil Sasi, Zixu Wang, John-Hanson Machado, Harrison Bai, Maryam Alasfour, Kahn Rhrissorrakrai, Chaya Levovitz, Brian P. Danysh, Kara Slowik, Raquel A. Jacobs, Matthew S. Davids, Cloud P. Paweletz, Ignaty Leshchiner, Laxmi Parida, Gad Getz, Jennifer R. Brown
Journal: Blood (2023)